Cardiovascular risk evaluation in patients with hypertension under pharmacotherapeutic follow-up in primary health care
Keywords:
Atenção Farmacêutica; Risco Cardiovascular; Hipertensão Arterial Sistêmica.Abstract
Objective: This longitudinal follow-up study, , aimed to investigate the influence of a Pharmaceutical Care service on the cardiovascular risk rate of patients with hypertension attending a Primary Care Unit located in Ceará.
Methods: A pharmacotherapeutic follow-up was carried out for 6 months according to the Dáder Method. At the beginning and end of the follow-up, the patients’ laboratory investigations and blood pressure results were registered. These indicators are necessary to calculate the risk rate from the Framingham Scale. The results were analyzed with Sigma Plot software using the Student t and Wilcoxon tests, set at a significance level of 5%.
Results: Significant differences were observed on the mean values of cardiovascular risk rate, reducing from 13,4% to 9,5% at the end of the study, and systolic blood pressure, initial value of 146,1mmHg and final value of 128,7mmHg, representing reductions of 29% and 11,9% of the initial value, respectively. The reductions tended to be proportional to the length of the follow-up.
Conclusion: Our findings suggest that the pharmacotherapeutic follow-up can effectively reduce cardiovascular risk rate and systolic blood pressure. These findings emphasize the importance of the practice of Pharmaceutical Care in patients with hypertension as a good strategy to improve their current health status and the prevention of future complications.
Descriptors: Pharmaceutical Care; Cardiovascular Risk; Arterial Systemic Hypertension.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
The authors hereby transfer, assign, or otherwise convey to RBFHSS: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print republish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to RHFHSS with this document.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Serlf-archiving policy
This journal permits and encourages authors to post and archive the final pdf of the articles submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.
